IMPACT OF ANTIBIOTIC RESISTANCE ON HEALTHCARE OUTCOMES
Article Sidebar
Main Article Content
Abstract
Antibiotic resistance (ABR) has arisen as a critical concern in contemporary
healthcare, significantly impacting patient outcomes, healthcare systems, and worldwide public
health. As bacteria develop resistance to widely utilized antibiotics, infections become
progressively challenging to manage, leading to prolonged hospitalizations, elevated treatment
expenses, and heightened morbidity and fatality rates. This study examines the effects of ABR on
healthcare outcomes, encompassing clinical, economic, and systemic difficulties it poses. The
paper emphasizes the significance of antimicrobial stewardship programs in alleviating these
consequences and offers recommendations for improving existing hospital policies and
procedures.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J.,
... & Trivedi, K. K. (2016). Implementing an antibiotic stewardship program: Guidelines by the
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of
America. Clinical Infectious Diseases, 62(10), e51-e77.
Baxter, C. G., Russell, C., Duncan, H., Farrell, S., Law, S., Baker, J., & Denning, D. W. (2016).
Clinical and laboratory features of invasive aspergillosis and the significance of aspergillus in
respiratory samples in acute leukaemia and haematopoietic stem cell transplantation. British
Journal of Haematology, 139(3), 504-515.
Centers for Disease Control and Prevention (2019). Antibiotic resistance threats in the United
States. Retrieved from https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threatsreport-508.pdf
Cosgrove, S. E., & Carmeli, Y. (2003). The impact of antimicrobial resistance on health and
economic outcomes. Clinical Infectious Diseases, 36(11), 1433-1437.
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., ...
& Hooton, T. M. (2007). Infectious Diseases Society of America and the Society for Healthcare
Epidemiology of America guidelines for developing an institutional program to enhance
antimicrobial stewardship. Clinical Infectious Diseases, 44(2), 159-177.
Dyar, O. J., Huttner, B., Schouten, J., & Pulcini, C. (2017). What is antimicrobial stewardship?
Clinical Microbiology and Infection, 23(11), 793-798.
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., ... &
Piddock, L. J. V. (2016). Understanding the mechanisms and drivers of antimicrobial
resistance. The Lancet, 387(10014), 176-187.
Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF
INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED
CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of
Medical Education: Experience, Problems, Prospects, 66.
Jiyanboevich, Y. S., Aslam, I., & Soatboyevich, J. N. (2024). FAILURE OF THE HEART
DETERMINATION PROTEOMIC PROFILING RELATED TO PATIENTS WHO ARE
ELDERLY. Research Focus, 3(1), 198-203.
Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating
Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and
Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141.
Shahzoda, K., Aslam, I., Ashraf, A., Ergashboevna, A. Z., & Ergashboevna, E. M. (2024).
ADVANCEMENTS IN SURGICAL TECHNIQUES: A COMPREHENSIVE
REVIEW. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va
rivojlanish omillari, 31(2), 139-149.RESEARCH FOCUS | VOLUME 3 | ISSUE 10 | 2024
ISSN: 2181-3833 ResearchBip (12.32) | Google Scholar | Index Copernicus (ICV69.78)
Research Focus International Scientific Journal, Uzbekistan 138 https://refocus.uz/
Aslam, I., & Jiyanboyevich, Y. S. (2023). THE COMMON PROBLEM OF
INTERNATIONAL STUDENTS AND ITS SOLUTION AND UNEXPECTED
CHALLENGES OF WORKING WITH FOREIGN TEACHER. Internationalization of
Medical Education: Experience, Problems, Prospects, 66.
Nodirovna, A. R., Maksudovna, M. M., Aslam, I., & Ergashboevna, A. Z. (2024). Evaluating
Novel Anticoagulant and Antiplatelet Drugs for Thromboembolic Illness Prevention and
Treatment. International Journal of Alternative and Contemporary Therapy, 2(5), 135-141.
Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood
Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and
Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.
Aslam, I., Jiyanboevich, Y. S., & Rajabboevna, A. R. (2023). Apixaban vs Rivaroxaban Blood
Thinner Use Reduced Stroke and Clot Risk in Patients with Heart Disease and
Arrhythmia. Rivista Italiana di Filosofia Analitica Junior, 14(2), 883-889.